Dr AJEET KUMAR
All India Institute of Medical Sciences, Patna, Indian Institute of Technology BHU, Central University of South Bihar, Nalanda College Biharsharif, Institute of Forest Productivity
0000-0002-5411-2783
About
Dr. Ajeet Kumar is a Scientist- C at the All India Institute of Medical Sciences (AIIMS), Patna. He is actively involved in haematological and cancer research, with a focus on advancing healthcare through scientific innovation and translational research. His work contributes to the development of molecular-based cancer treatment and improved patient care. Dr. Kumar has participated in several multidisciplinary research projects and has published scientific papers in national and international journals. His research interests include biomedical sciences, molecular diagnostics, clinical research, and public health. He collaborates with clinicians, researchers, and academic institutions to promote innovation in medical science. In addition to his research activities, Dr. Kumar is committed to mentoring young researchers and promoting ethical scientific practices. His contributions to research and healthcare continue to support the mission of AIIMS Patna in improving medical education, research, and patient care.
Employment
-
All India Institute of Medical Sciences, Patna Scientist C2025 - Present
-
Indian Institute of Technology BHU Junior Research Fellow2018 - 2019
-
Institute of Forest Productivity Technical Officer2016 - 2018
Education
-
Central University of South Bihar MSc Biotechnology2013 - 2016
-
Nalanda College Biharsharif BSc Biotechnology2010 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- Genetic Landscape and Linkage Analysis of Factor VIII Gene Markers in Indian Women: Improving Carrier Detection for Haemophilia A Save
- Emerging Gene-Based and Targeted Therapies for Hemophilia A and B and its Impact on Hemostasis, Quality of Life, and Cost Save
- A Review Article on Novel Antifungal Agents with Different Heterocyclic Nucleus Save
- Advancements and Challenges in Hemophilia B: Understanding Genetic, Clinical, and Therapeutic Dimensions Save
- Melittin induces apoptosis, Mitochondrial membrane potential, Reactive Oxygen species, and cell cycle arrest against T-cell acute lymphoblastic leukemia (T-ALL) in vitro. Save
- Clinical, Demographic, And Haematological Profile of Haemophilia Patients at Sir Sunder Lal Hospital Varanasi With CoE Haemoglobinopathies And Day Care Centre Save
- Imatinib-resistant Chronic Myeloid Leukaemia Patients' BCR-ABL1 Kinase Domain Mutations in the Eastern Indian Population Save
- Inflammation and Cancer Save
- BIO-SIGNAL PROCESSING Save
- Higher incidence of co-expression of BCR-ABL fusion transcripts in an Eastern Indian population Save